Rebates are bad enough without invoices based on unconstitutional benefit claims

Companies with patented PBS-listed medicines likely now repay more in rebates than they retain in actual payments. To make matters worse, the annual report suggests they may have been repaying more than necessary due to the unconstitutional claiming of PBS benefits for some medicines reimbursed under the Highly Specialised Drugs Program. …